A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this study is to evaluate the efficacy of guselkumab in pediatric participants with moderately to severely active ulcerative colitis at the end of maintenance therapy among participants who were induction responders.
Epistemonikos ID: f6bdb85f7320e06f274e34e079037082ed1c0089
First added on: May 15, 2024